<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FA143EC1-E637-4E0C-80ED-0EA8ED214038"><gtr:id>FA143EC1-E637-4E0C-80ED-0EA8ED214038</gtr:id><gtr:name>University of Leuven</gtr:name><gtr:address><gtr:line1>Oude Markt 13</gtr:line1><gtr:line2>Box 5005</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/01128021-52EB-4EFB-B0E5-437538E9F785"><gtr:id>01128021-52EB-4EFB-B0E5-437538E9F785</gtr:id><gtr:name>Almirall</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E9838C7-0C12-462C-B883-1C924A98C689"><gtr:id>4E9838C7-0C12-462C-B883-1C924A98C689</gtr:id><gtr:name>Afferent Pharmaceuticals Inc.</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>National Heart and Lung Institute</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FA143EC1-E637-4E0C-80ED-0EA8ED214038"><gtr:id>FA143EC1-E637-4E0C-80ED-0EA8ED214038</gtr:id><gtr:name>University of Leuven</gtr:name><gtr:address><gtr:line1>Oude Markt 13</gtr:line1><gtr:line2>Box 5005</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/01128021-52EB-4EFB-B0E5-437538E9F785"><gtr:id>01128021-52EB-4EFB-B0E5-437538E9F785</gtr:id><gtr:name>Almirall</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E9838C7-0C12-462C-B883-1C924A98C689"><gtr:id>4E9838C7-0C12-462C-B883-1C924A98C689</gtr:id><gtr:name>Afferent Pharmaceuticals Inc.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BDA78D1E-1BC3-45B7-AD4E-D0BEF05B9980"><gtr:id>BDA78D1E-1BC3-45B7-AD4E-D0BEF05B9980</gtr:id><gtr:firstName>Maria</gtr:firstName><gtr:otherNames>Gabriela</gtr:otherNames><gtr:surname>Belvisi</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3571241F-29B5-41F9-AFA9-0D81BCC1CAF4"><gtr:id>3571241F-29B5-41F9-AFA9-0D81BCC1CAF4</gtr:id><gtr:firstName>Eric</gtr:firstName><gtr:surname>Dubuis</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9CF3D997-EE83-49A2-8AEA-28F2259C6D0A"><gtr:id>9CF3D997-EE83-49A2-8AEA-28F2259C6D0A</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Birrell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C982739C-5B42-4285-8DDB-4877CCFCC0F3"><gtr:id>C982739C-5B42-4285-8DDB-4877CCFCC0F3</gtr:id><gtr:firstName>Jacky</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK020293%2F1"><gtr:id>7AA17362-5B64-4000-9464-28CB51EACE66</gtr:id><gtr:title>MICA: Investigation into the mechanisms that drive cough in health and disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K020293/1</gtr:grantReference><gtr:abstractText>Coughing is a reflex action started by stimulation of sensory nerves in the lining of the respiratory passages which are the tubes we use to breathe. When a person coughs, there is a short intake of breath and the larynx (the voice box) closes momentarily. The abdominal and chest muscles used for breathing contract, which in turn increases the pressure needed to drive air out the lungs when the larynx re-opens. Cough is a reflex mechanism that helps clear foreign material and secretions from the airways. However, it may also be the first and most persistent symptom of many inflammatory airways diseases, including asthma, COPD, post viral infections, pulmonary fibrosis, bronchiectasis and cough can also be present when a cause cannot be identified. In these situations cough may present as a debilitating symptom and can adversely affect the quality of a patient's life in multiple ways for example by causing exhaustion, self consciousness, insomnia, horseness, musculoskeletal pain, sweating, urinary incontinence and in severe cases patients can break ribs through excessive coughing. Despite these facts, cough is a largely ignored research area and novel anti-tussive agents are lacking. Treatment options are limited and recent meta-analysis concluded that over the counter (OTC) remedies are ineffective plus there is increasing concern about their use in children. Understanding the mechanisms involved in initiating cough will uncover novel therapeutic targets which will impact significantly on patient quality of life and a reduction in associated healthcare costs. The cough reflex is initiated by activation of airway sensory afferent nerves. We hypothesize that agents that inhibit sensory nerve activity will also inhibit the cough reflex. In this proposal we describe pre-clinical data from our laboratory, genetic association data in respiratory disease from the scientific literature and our data from clinical studies implicating certain proteins or ion channels called Transient Receptor Potential (TRP) channels as 'master controllers' of the cough reflex. There are a number of these channels that are expressed in airway sensory nerves and so in this project we will be evaluating their importance using pharmacology (tool compounds that block these targets) or genetically modified mice (which are bred without each of the TRP channels) in isolated nerve experiments (using animal and human tissue) and in animal models of cough. We will investigate their role in the cough response under normal conditions and then in models which are configured to resemble asthma related cough, post-viral cough and that associated with chronic obstructive pulmonary disease (COPD). Finally we will evaluate the role of these channels in patients that demonstrate chronic cough of different aeitiologies (eg. Asthma, COPD, smokers, post-viral, and chronic cough of no known cause).The aim of these studies is to identify possible novel drug targets which can be used as starting points for drug discovery programmes to find novel cough therapies to treat this debilitating symptom. Another output from this grant that we hope to achieve is to establish if the various animal model systems we use to investigate this hypothesis actually represent the human cough and that the systems used to test therapeutics are predictive of anti-tussive activity in patients.</gtr:abstractText><gtr:technicalSummary>The goal of this collaboration would be to provide insight into the mechanisms that drive cough in health and disease and to understand the similarities and differences in exaggerated cough that is present in specific patient groups. This would provide novel target validation data and inform a translational and predictive screening pathway from high throughput assays to clinical trial design. 

(1) Investigate which endogenous mediators (produced in inflammatory diseases) and environmental irritants are able to elicit cough, which fibre type they activate and evaluate their mechanism of action.
(2) Evaluate the utility of selective ligands in cell lines overexpressing the corresponding target protein. Establish which TRP channels are involved in the activation of airway sensory nerves and evoke a cough reflex under 'normal' conditions using selective ligands and vagal tissue from gene deleted animals (eg. TRPV1, TRPV4, TRPA1). If Ad and C-fibre afferents are involved preferentially evaluate the role of NaV channels (in particular NaV1.7). We will perform pharmacokinetic/pharmacodynamic (PK/PD) modelling integrating compound exposure information with in vitro and in vivo data which will aid in the interpretation of the data sets.
(3) Investigate changes in the function and phenotype of airway specific afferents and cough in disease models (eg. allergen, sensitised and challenged guinea-pigs; CS exposed guinea-pigs) as previously described by our lab and others using selective ligands. Develop a model of post viral cough (mirroring the most appropriate clinical phenotype eg. H1N1, rhinovirus). 
(4) Perform clinical studies using ion channel specific tussive stimuli (eg. TRPV1, capsaicin; TRPA1, cinnamaldehyde; TRPV4, investigate appropriate stimuli, our pre-clinical studies suggest hypertonic saline may partially activate through TRPV4) across the relevant patient groups (normal, non-smokers, smokers, asthmatics, COPD, idiopathic coughers).</gtr:technicalSummary><gtr:potentialImpactText>Who will benefit from this research and how? 

Researchers: Sensory neurobiologists, respiratory physiologists and pharmacologists and respiratory clinicians will benefit from the proposed project through interaction with the PI's and researchers involved in this project. Interactions at meetings and publications in peer review journals will inform research in other laboratories.

Students (basic science and medical): will learn from the wide range of scientists involved in this project who have basic science, clinical and industrial experience. In particular, at Imperial scientists will be able to learn from top class scientists involved in doing complex electrophysiology and in vivo models.The lack of in vivo physiologists and pharmacologists is still apparent in spite of recent initiatives and so it is still essential that those people that possess these skills train young researchers so as to strengthen the UK in vivo skills base. Birrell and Belvisi train their own staff in these methodologies and together with the named scientists (Eric Dubuis, Sarah Maher) also run practical modules in which they are involved in 'hands on' teaching (BSc, MRes, Phd students) thereby contributing to the training of youngsters in the UK and increasing the research capacity in this area. Outside the UK the group always takes holiday experience placements and visiting fellows from across the globe that will benefit from the expertise and skills they can learn. Outreach events have also been hosted.

Patients:Treatment options are limited and recent meta-analysis concluded that over the counter (OTC) remedies are ineffective plus there is increasing concern about their use in children. Understanding the mechanisms involved in initiating cough will uncover novel therapeutic targets which will impact significantly on patient quality of life and a reduction in associated healthcare costs.

Government and NHS funding bodies: Cough is the most frequent reason for consultation with a family doctor, or with a general or respiratory physician. In the UK, over &amp;pound;93 million/year is spent on over the counter anti-tussives of questionable efficacy Cough has a major impact on the UK economy with absenteeism from work, reduced productivity, physician consultations and prescription costs estimated at &amp;pound;1 billion annually. Chronic cough is often associated with an underlying inflammatory condition (eg. lung infections, asthma, COPD, pulmonary fibrosis, bronchiectasis, lung cancer) and can also be iodiopathic in nature with no known cause. Despite these facts, cough is a largely ignored research area and novel anti-tussive agents are lacking. 

The European Respiratory Society (ERS) published guidelines on the management of cough. Belvisi and Smith were on this taskforce and Smith is also a member of the American College of Chest Physicians taskforce. The aim was to provide consensus regarding the diagnosis and treatment of cough in both adults and children. In 2004, the ERS produced a practical document, which provides helpful guidance to researchers, clinicians, the pharmaceutical industry and regulatory authorities. This document included recommendations on the following key elements: 1) safe standardised methods of inhalation cough challenge; 2) reliable, reproducible and relevant clinical cough recording and analysis; 3) clinical assessment of cough-related quality of life; 4) appropriate animal models in which to evaluate novel cough treatments; and 5) areas for future research. We believe that this document helped to improved patient care, enhance the quality of cough research and ultimately assist in the development of effective new therapies. Belvisi and Smith remain on these committees and in a key position to influence the field and inform on the cutting edge research they are performing whithin their laboratories. (Eur Respir J. 2004 Sep;24(3):481-92; Eur Respir J. 2007 Jun;29(6):1256-76).</gtr:potentialImpactText><gtr:fund><gtr:end>2017-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>663728</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Almirall</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>MICA-Almirall-Manchester University</gtr:description><gtr:id>012334C5-E875-4605-9D49-7DE4C9228AE3</gtr:id><gtr:impact>Multidiciplinary collaborating bringing together Imperial (pre-clinical), Almirall (Industry) and Manchester University (Clinical)</gtr:impact><gtr:outcomeId>ma1mvF35v8h-1</gtr:outcomeId><gtr:partnerContribution>All outlined in the MICA form</gtr:partnerContribution><gtr:piContribution>All outlined in the MICA form</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Afferent Pharmaceuticals Inc.</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Afferent Pharma</gtr:description><gtr:id>01E96E30-9B17-43C4-AD1E-1130C215F463</gtr:id><gtr:impact>Joint publication (Bonvini et al., 2016-in publication output list)</gtr:impact><gtr:outcomeId>56d466484628f0.96084941-1</gtr:outcomeId><gtr:partnerContribution>Synthesised molecule for proof of concept pre-clinical studies</gtr:partnerContribution><gtr:piContribution>We performed all the research experiments and developed the hypotheses.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leuven</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Collaboration with experts in Transient receptor potential channels</gtr:description><gtr:id>03DBF791-F752-4127-B321-9A2A54F5EB04</gtr:id><gtr:impact>Generation of data that will eventually lead to a joint publication</gtr:impact><gtr:outcomeId>545a64a21d7fa1.56841307-1</gtr:outcomeId><gtr:partnerContribution>Provision of expertise and novel chemistry</gtr:partnerContribution><gtr:piContribution>Assessing the role of novel ion channels in respiratory neurons that may be involved in mediating reflex events.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Combat my Cough</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1DC70653-B7CE-483B-95CF-EE017E70435E</gtr:id><gtr:impact>My team and I gave a series of presentations about our research. A specific question and answer session was held and much discussion with patients about their condition was provoked.

Increased patient interest and recruitment to studies.
Requests for further similar events.</gtr:impact><gtr:outcomeId>545e958f112f63.15450285</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.combatmycough.com</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Body Experience' organised by Manchester Museum</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>40D73EE1-D57D-423B-9BD7-B80A82A213B4</gtr:id><gtr:impact>We performed lung function testing and played cough sounds to children and their parents attending this event.
This provoked discussion about lung symptoms, health and research.

Have been invited to participate again next year.</gtr:impact><gtr:outcomeId>545e96b4aa99b4.18805737</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>72A44872-6030-43B9-8DC4-EB0A3E34B68C</gtr:id><gtr:impact>Attend by school children and the public. Increase awareness of medical science and the use of animals in research.

Asked to participate in other events</gtr:impact><gtr:outcomeId>EfhENqdZApR</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Attended a Parlimentary links day (science &amp; diversity)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>26CB6E8D-104A-451B-9CC1-88D40F634D9E</gtr:id><gtr:impact>Attended and discussed with policy makers

Contributed to the British Pharmacological Society response to the House of Commons select committtee inquiry into women in STEM careers</gtr:impact><gtr:outcomeId>DmvbxpnCUYd</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Involvement (Manchester)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>573566D2-B037-4BCD-A226-29317877044D</gtr:id><gtr:impact>Out clinical collaborators (MRC grant partners on this award) in Manchester hold an event each year to keep chronic cough patients up to date with the work they are doing in their clinic and through our research to find a cure for chronic cough. Combat my Cough is an opportunity to listen to and talk to the research team, but also for you to meet and talk to other sufferers with the condition.

 http://www.combatmycough.com/#!events/c1k9b</gtr:impact><gtr:outcomeId>56d46cd35c4a03.90427844</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.combatmycough.com/#!events/c1k9b</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>497719</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs Infrastructure grant NC/P001041/1 (01/10/2016-30/09/2019) Human Tissue Models for Lung Disease</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:fundingRef>NC/P001041/1</gtr:fundingRef><gtr:id>EE1C01B1-A2DA-4C5F-9649-4740A4082620</gtr:id><gtr:outcomeId>58b546fed1e723.47110417</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>214600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Industrial CASE Studentship 2015</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/N018567/1</gtr:fundingRef><gtr:id>F071AFA6-000D-4514-B900-9B7A3730F53F</gtr:id><gtr:outcomeId>56d46805d88ef8.60935223</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>House of Commons Select Committee inquiry into women in STEM careers</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>711DAC8B-3C00-4E5E-A7BB-BFA5C4C88C65</gtr:id><gtr:outcomeId>Z68yjt2JYmG</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NC3Rs Asthma Advisory Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>54FAE951-4BA2-4906-8A2A-24462617DBA2</gtr:id><gtr:outcomeId>545a5bd5988498.17548209</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8E6F3F10-2824-47EE-B083-DE32E826A3AD</gtr:id><gtr:title>Prostaglandin D2 and the role of the DP1, DP2 and TP receptors in the control of airway reflex events.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf94e702df2683997992c62be33df36b"><gtr:id>bf94e702df2683997992c62be33df36b</gtr:id><gtr:otherNames>Maher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>545915d14e7ef7.99258289</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2BD271C-3192-43D6-9C01-4FD94793AE96</gtr:id><gtr:title>CD4? and CD8? T cells play a central role in a HDM driven model of allergic asthma.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b55a51605949dd812ca5f0f589b7cd6a"><gtr:id>b55a51605949dd812ca5f0f589b7cd6a</gtr:id><gtr:otherNames>Raemdonck K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>585d5052d56485.72657313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06645010-9736-4508-9DCA-C6F0056B9A4E</gtr:id><gtr:title>Neurophenotypes in Airway Diseases. Insights from Translational Cough Studies.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5c62caf0f822d853f7fdf984d2f220f"><gtr:id>b5c62caf0f822d853f7fdf984d2f220f</gtr:id><gtr:otherNames>Belvisi MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>56e08c3dcf8855.32641299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6666A702-AB1C-43CB-B81F-30BE567B8761</gtr:id><gtr:title>Transient receptor potential cation channel, subfamily V, member 4 and airway sensory afferent activation: Role of adenosine triphosphate.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0349ed525e56a7f6dd74b0a76f194840"><gtr:id>0349ed525e56a7f6dd74b0a76f194840</gtr:id><gtr:otherNames>Bonvini SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56e08c3da96cb1.50333311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F95D2B04-D30D-4322-84C6-DF1D3E9EC718</gtr:id><gtr:title>Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials.</gtr:title><gtr:parentPublicationTitle>BMJ open respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73e082f3b798aa0aaef6df16471e0392"><gtr:id>73e082f3b798aa0aaef6df16471e0392</gtr:id><gtr:otherNames>McGarvey L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2052-4439</gtr:issn><gtr:outcomeId>5aaa3396bb7554.82116334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FD18983-8E69-4405-B30F-A24D991E926D</gtr:id><gtr:title>Chronic Cough.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740b47608c2a17faae775070e5702f3"><gtr:id>5740b47608c2a17faae775070e5702f3</gtr:id><gtr:otherNames>Smith JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>58c54c31e49a23.79634215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>984C0D45-1729-4A3D-B37A-8D8C13AB7199</gtr:id><gtr:title>Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3b657577dc9fc228f1740c838d26434"><gtr:id>c3b657577dc9fc228f1740c838d26434</gtr:id><gtr:otherNames>Birrell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5675e3c5b2e0b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86918D52-D83A-42E5-BC2F-8DBE9ADAEA4E</gtr:id><gtr:title>XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5c62caf0f822d853f7fdf984d2f220f"><gtr:id>b5c62caf0f822d853f7fdf984d2f220f</gtr:id><gtr:otherNames>Belvisi MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>5a578c18175bf8.39494780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78F7051D-8870-48D4-BDDA-B7376F330136</gtr:id><gtr:title>Pre-clinical studies in cough research: role of Transient Receptor Potential (TRP) channels.</gtr:title><gtr:parentPublicationTitle>Pulmonary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c75c3f5aed9961aead9453022804d3"><gtr:id>e1c75c3f5aed9961aead9453022804d3</gtr:id><gtr:otherNames>Grace MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1094-5539</gtr:issn><gtr:outcomeId>pm_13650_20_23474212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A736881-08AE-4D7E-8648-576906C81A1C</gtr:id><gtr:title>XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5c62caf0f822d853f7fdf984d2f220f"><gtr:id>b5c62caf0f822d853f7fdf984d2f220f</gtr:id><gtr:otherNames>Belvisi MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>5aaa339758bc37.54244617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10201FB2-BC73-4A44-8A16-EADF40156377</gtr:id><gtr:title>Capsaicin-evoked cough responses in asthmatic patients: Evidence for airway neuronal dysfunction.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58fc8298a6aeafc2d5c812c2490ca4dc"><gtr:id>58fc8298a6aeafc2d5c812c2490ca4dc</gtr:id><gtr:otherNames>Satia I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>58c54c31251981.62176685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CDD3EE3-518E-4060-B49C-32FEC2614F76</gtr:id><gtr:title>Role of transient receptor potential and pannexin channels in cigarette smoke-triggered ATP release in the lung.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86657e337abedb83adf26de5d8f16dcd"><gtr:id>86657e337abedb83adf26de5d8f16dcd</gtr:id><gtr:otherNames>Baxter M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>doi_55f9849849d52f26</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>231F7EF4-4789-4D5E-B2B2-25CBDB66B107</gtr:id><gtr:title>Theophylline inhibits the cough reflex through a novel mechanism of action.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca7bbf9d2f4641822911b446142a2085"><gtr:id>ca7bbf9d2f4641822911b446142a2085</gtr:id><gtr:otherNames>Dubuis E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>doi_55f9849849c241f4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>695E9E44-5FBB-4A34-9FC3-1F12AC169883</gtr:id><gtr:title>Pharmacologic and Nonpharmacologic Treatment for Acute Cough Associated With the Common Cold: CHEST Expert Panel Report.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44db035eac41470a89bc0473fe2b6cf4"><gtr:id>44db035eac41470a89bc0473fe2b6cf4</gtr:id><gtr:otherNames>Malesker MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>5aaa35d94267d5.84682435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E81EDE3-EB0B-41C2-AC5C-035F46736DEB</gtr:id><gtr:title>The interaction between bronchoconstriction and cough in asthma.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58fc8298a6aeafc2d5c812c2490ca4dc"><gtr:id>58fc8298a6aeafc2d5c812c2490ca4dc</gtr:id><gtr:otherNames>Satia I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>58c54c314b6535.61876615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2126900-C796-4E6F-BDA5-B4443235B171</gtr:id><gtr:title>Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough .</gtr:title><gtr:parentPublicationTitle>International journal of clinical pharmacology and therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740b47608c2a17faae775070e5702f3"><gtr:id>5740b47608c2a17faae775070e5702f3</gtr:id><gtr:otherNames>Smith JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0946-1965</gtr:issn><gtr:outcomeId>5aaa33972c20e0.69276017</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7373D076-3BEC-4043-8913-7B9AF1664345</gtr:id><gtr:title>Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8603744bac0fd9c512c0c37ca4382a6a"><gtr:id>8603744bac0fd9c512c0c37ca4382a6a</gtr:id><gtr:otherNames>Edwards MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>5aaa3397081bd4.36654741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FC6BDDB-44C6-4503-829C-57A12F654E6A</gtr:id><gtr:title>Characterisation of a murine model of the late asthmatic response.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71c797870d16592fd8eeadf6ac79a715"><gtr:id>71c797870d16592fd8eeadf6ac79a715</gtr:id><gtr:otherNames>Baker K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>5a2fd65d36e1e3.54414245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB97CFB9-2E1C-4F39-A87B-63C85016EBC0</gtr:id><gtr:title>Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: A beneficial off-target effect?</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3b657577dc9fc228f1740c838d26434"><gtr:id>c3b657577dc9fc228f1740c838d26434</gtr:id><gtr:otherNames>Birrell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>doi_55f9849849cb9206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23381F79-261E-43E1-8DE5-8D75AA74AB0A</gtr:id><gtr:title>Therapeutic advances for treatment-resistant cough.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5c62caf0f822d853f7fdf984d2f220f"><gtr:id>b5c62caf0f822d853f7fdf984d2f220f</gtr:id><gtr:otherNames>Belvisi MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56cdc8d9678e62.62720496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B62B4BEC-B391-4824-8C68-0855CAAF6041</gtr:id><gtr:title>Harvesting, isolation, and functional assessment of primary vagal ganglia cells.</gtr:title><gtr:parentPublicationTitle>Current protocols in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca7bbf9d2f4641822911b446142a2085"><gtr:id>ca7bbf9d2f4641822911b446142a2085</gtr:id><gtr:otherNames>Dubuis E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1934-8282</gtr:issn><gtr:outcomeId>pm_540e15ce15c397867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B171527-8929-4EDB-B0F2-B85E84783F03</gtr:id><gtr:title>Cough hypersensitivity syndrome: clinical measurement is the key to progress.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/113faf4ab829dc948e8c948bccee6f7a"><gtr:id>113faf4ab829dc948e8c948bccee6f7a</gtr:id><gtr:otherNames>Morice AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>56cdc8d9028ac0.17034163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8046A20C-7C45-4B13-8CA2-8BBE52D6D14A</gtr:id><gtr:title>Role of the ion channel, transient receptor potential cation channel subfamily V member 1 (TRPV1), in allergic asthma.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71c797870d16592fd8eeadf6ac79a715"><gtr:id>71c797870d16592fd8eeadf6ac79a715</gtr:id><gtr:otherNames>Baker K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>585d3c8fe2b714.58559110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1896C29-46B0-4358-B5AD-C6D8D80D99BA</gtr:id><gtr:title>Mechanistic link between diesel exhaust particles and respiratory reflexes.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09505a8d43d669fc14c6d6cf664dd5db"><gtr:id>09505a8d43d669fc14c6d6cf664dd5db</gtr:id><gtr:otherNames>Robinson RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>5a578b9c3b6ab9.14911166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EC310DB-2317-40DC-979D-8B717DE9CDB0</gtr:id><gtr:title>P6 Menthol Has Beneficial Effects In The Airways Through A Trpm8-independent Mechanism</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70f7ef6b203cc099aa88717a7e3a31da"><gtr:id>70f7ef6b203cc099aa88717a7e3a31da</gtr:id><gtr:otherNames>Maher S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5675f1818e61a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8125D481-AC83-4AF4-B38B-F141F5D93CEA</gtr:id><gtr:title>Targeting TRP channels for chronic cough: from bench to bedside.</gtr:title><gtr:parentPublicationTitle>Naunyn-Schmiedeberg's archives of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0349ed525e56a7f6dd74b0a76f194840"><gtr:id>0349ed525e56a7f6dd74b0a76f194840</gtr:id><gtr:otherNames>Bonvini SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-1298</gtr:issn><gtr:outcomeId>doi_55f98498497743d7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2ACFC50F-9F47-4B46-AD89-1287033F14DF</gtr:id><gtr:title>Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a04c7083d91a136bbf719224e23c56fc"><gtr:id>a04c7083d91a136bbf719224e23c56fc</gtr:id><gtr:otherNames>Wortley MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>5a2fd69e8684a3.27192243</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C919006-15C7-4C30-9C28-4A6940B0518C</gtr:id><gtr:title>Transient receptor potential (TRP) channels in the airway: role in airway disease.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c75c3f5aed9961aead9453022804d3"><gtr:id>e1c75c3f5aed9961aead9453022804d3</gtr:id><gtr:otherNames>Grace MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_540e198e1989d5609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80E0A586-D85D-444E-B353-8E349061A208</gtr:id><gtr:title>Objective Cough Frequency, Airway Inflammation, and Disease Control in Asthma.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b73e4248d193d2d1c55d98f56aa22dd7"><gtr:id>b73e4248d193d2d1c55d98f56aa22dd7</gtr:id><gtr:otherNames>Marsden PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>58c54c329d9b82.40272694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3B02817-41FB-4914-9294-7756AE716F81</gtr:id><gtr:title>Antitussive drugs--past, present, and future.</gtr:title><gtr:parentPublicationTitle>Pharmacological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/540839cfd1060dc1c4cac4ec980536a7"><gtr:id>540839cfd1060dc1c4cac4ec980536a7</gtr:id><gtr:otherNames>Dicpinigaitis PV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0031-6997</gtr:issn><gtr:outcomeId>545e8d401bb662.38336974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1DE1D32-D3BA-4E48-924A-37E2013F4CFB</gtr:id><gtr:title>Cough Due to TB and Other Chronic Infections: CHEST Guideline and Expert Panel Report.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/421fb2e1f1ce6bf86ddf1129487253fa"><gtr:id>421fb2e1f1ce6bf86ddf1129487253fa</gtr:id><gtr:otherNames>Field SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>5aaa35d8d66307.17869238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0E7EF98-8389-4893-81F6-76157F54AC61</gtr:id><gtr:title>Expert opinion on the cough hypersensitivity syndrome in respiratory medicine.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/113faf4ab829dc948e8c948bccee6f7a"><gtr:id>113faf4ab829dc948e8c948bccee6f7a</gtr:id><gtr:otherNames>Morice AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>545e8d3f5dc428.67477010</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K020293/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>